Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

AxyS advances development of APC-2059 for two different indications

Jan. 15, 2001

Nonpeptide caspase inhibitor holds promise for patients with fulminant hepatic failure

Jan. 15, 2001

Phase III compound for liver diseases licensed by Interneuron

Jan. 12, 2001

FDA clearance sought to begin clinical trials of levovirin

Jan. 11, 2001

IMP dehydrogenase inhibitors potentiate anti-HBV activity of nucleoside analogues

Jan. 11, 2001

Prospective trial compares efficacy of teprenone and rabeprazole against NSAID-induced GI lesions

Jan. 10, 2001

New series of sphingomyelinase inhibitors described by Ono researchers

Jan. 8, 2001

Pregabalin may have beneficial effects in the treatment of abdominal pain

Jan. 3, 2001

Global rights for novel Japanese antiviral agent granted to Lilly

Jan. 2, 2001

Elan/Incara partnership plans immediate entry into pivotal IBD trials for OP-2000

Jan. 2, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...